These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27346606)

  • 61. A case of lichen amyloidosus with Riehl's melanosis-like lesion on the face: a histological and electron microscopic study of Civatte body and amyloid.
    Masu SI; Sato A; Seiji M
    J Dermatol; 1979 Jun; 6(3):161-72. PubMed ID: 393745
    [No Abstract]   [Full Text] [Related]  

  • 62. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
    Spierings NMK
    J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Riehl melanosis treated successfully with Q-switch Nd:YAG laser.
    Smucker JE; Kirby JS
    J Drugs Dermatol; 2014 Mar; 13(3):356-8. PubMed ID: 24595582
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of 577 nm pro-yellow laser in the treatment of melasma: a prospective split-face study.
    Mohamed EM; Younes AH; Hussein GM
    J Cosmet Laser Ther; 2020 Feb; 22(2):107-110. PubMed ID: 32216566
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
    Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
    Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma.
    Debasmita B; Raj C; Ishan A; Ipsita D
    J Cosmet Dermatol; 2022 Jul; 21(7):2801-2807. PubMed ID: 34636493
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
    Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
    Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimizing Q-switched lasers for melasma and acquired dermal melanoses.
    Aurangabadkar SJ
    Indian J Dermatol Venereol Leprol; 2019; 85(1):10-17. PubMed ID: 30027914
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
    Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
    J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined isobutylamido thiazolyl resorcinol and low-fluence Q-switched Nd: YAG laser for the treatment of facial hyperpigmentation: A randomized, split-face study.
    Vachiramon V; Leerunyakul K; Kositkuljorn C; Chayavichitsilp P
    J Cosmet Dermatol; 2021 Jun; 20(6):1724-1731. PubMed ID: 33118677
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Efficacy of Q-Switched ND:YAG 1064 nm Laser in Recalcitrant Macular Amyloidosis: A Case Report.
    Khurana N; Urman C
    J Drugs Dermatol; 2016 Nov; 15(11):1456-1458. PubMed ID: 28095562
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of 1064 nm Q-switched Nd:YAG laser and Jessner peeling in melasma treatment.
    Ertam Sagduyu I; Marakli O; Oraloglu G; Bulut Okut E; Unal I
    Dermatol Ther; 2022 Dec; 35(12):e15970. PubMed ID: 36346028
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of melasma by low-fluence 1064 nm Q-switched Nd:YAG laser.
    Sim JH; Park YL; Lee JS; Lee SY; Choi WB; Kim HJ; Lee JH
    J Dermatolog Treat; 2014 Jun; 25(3):212-7. PubMed ID: 23030603
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients.
    Choi JE; Lee DW; Seo SH; Ahn HH; Kye YC
    J Cosmet Dermatol; 2018 Dec; 17(6):1053-1058. PubMed ID: 30280474
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
    Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
    J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
    Moubasher AE; Youssef EM; Abou-Taleb DA
    Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream.
    Tourlaki A; Galimberti MG; Pellacani G; Bencini PL
    J Dermatolog Treat; 2014 Jun; 25(3):218-22. PubMed ID: 22385073
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Q-Switched Nd:YAG (532 nm) Laser Versus Intra-Dermal Tranexamic Acid for Treatment of Facial Ephelides: A Split Face, Randomized, Comparative Trial.
    Sayed KS; Tuqan S; Hilal RF
    Lasers Surg Med; 2021 Mar; 53(3):324-332. PubMed ID: 32592273
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of procedure-related postinflammatory hyperpigmentation using 1064-nm Q-switched Nd:YAG laser with low fluence in Asian patients: report of five cases.
    Kim S; Cho KH
    J Cosmet Dermatol; 2010 Dec; 9(4):302-6. PubMed ID: 21122049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.